ORGO
Organogenesis·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ORGO fundamentals
Organogenesis (ORGO) released its earnings on Nov 6, 2025: revenue was 150.86M (YoY +30.95%), beat estimates; EPS was 0.12 (YoY +33.33%), beat estimates.
Revenue / YoY
150.86M
+30.95%
EPS / YoY
0.12
+33.33%
Report date
Nov 6, 2025
ORGO Earnings Call Summary for Q3,2025
- Revenue Growth: Q3 2025 revenue up 31% YoY to $150.5M, driven by Advanced Wound Care and Surgical/Sports Medicine products.
- CMS Policy Impact: 2026 fee schedule removes 200+ non-PMA products, favoring Organogenesis' PMA-approved Apligraf, Affinity, and NuShield. Reimbursement rates for PMA products to remain higher than 510(k)/361 devices.
- ReNu Update: Phase III trial missed statistical significance but showed numerical improvement in pain. FDA RMAT designation secured; BLA submission planned post-December 12 meeting.
- 2025 Guidance: $500-525M net revenue (4-9% YoY growth), with EBITDA of $45.5-68.3M reflecting margin expansion from CMS policy and product mix.
- Market Outlook: ASPs to decline across market, but Apligraf's HOPD reimbursement rate increase and brand strength position company for share regain in 2026.
EPS
Revenue
Revenue & Expenses
ORGO has released its 2025 Q3 earnings report, with revenue of 150.86M, reflecting a YoY change of 30.98%, and net profit of 21.57M, showing a YoY change of 74.90%. The Sankey diagram below clearly presents ORGO's revenue sources and cost distribution.
Key Indicators
Organogenesis (ORGO) key financial stats and ratios, covering profitability, financial health, and leverage.
Organogenesis (ORGO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Organogenesis (ORGO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Organogenesis (ORGO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Organogenesis (ORGO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Organogenesis (ORGO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Organogenesis's management provide for the next earnings period?What is Organogenesis's gross profit margin?What factors drove the changes in Organogenesis's revenue and profit?What is the revenue and EPS growth rate for Organogenesis year over year?Did Organogenesis beat or miss consensus estimates last quarter?What is the market's earnings forecast for Organogenesis next quarter?What does Organogenesis do and what are its main business segments?What is Organogenesis's latest dividend and current dividend yield?
